Page last updated: 2024-11-06

thyroxine and Sleep Initiation and Maintenance Disorders

thyroxine has been researched along with Sleep Initiation and Maintenance Disorders in 7 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research Excerpts

ExcerptRelevanceReference
"Old studies in animals and unblinded studies in a few hyperthyroid patients suggested that L -carnitine is a periferal antagonist of thyroid hormone action at least in some tissues."9.09Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. ( Benvenga, S; Campenni, A; Lapa, D; Ruggeri, RM; Russo, A; Trimarchi, F, 2001)
"To evaluate the long-term safety and subjective sleep effects of ramelteon in adults with chronic insomnia."5.14Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. ( Richardson, GS; Wang-Weigand, S; Zammit, G; Zhang, J, 2009)
"Old studies in animals and unblinded studies in a few hyperthyroid patients suggested that L -carnitine is a periferal antagonist of thyroid hormone action at least in some tissues."5.09Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. ( Benvenga, S; Campenni, A; Lapa, D; Ruggeri, RM; Russo, A; Trimarchi, F, 2001)
"Further, the relapse and recurrence rates within 3 months after respective treatments were also measured."2.78Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia. ( Gao, D; Jiang, CG; Yi, ML; Yue, FG; Zhang, T, 2013)
"This study included 30 patients with primary insomnia (PI), 30 patients with depression-comorbid insomnia (DCI), and 30 healthy controls for exploring the alterations in the hypothalamus-pituitary-adrenal/thyroid axes' hormones and gonadotropin-releasing hormone (GnRH)."1.39Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research. ( Chen, GH; Jiang, S; Li, ZH; Shen, J; Xia, L, 2013)
"Prednisone was started 1 d after RAI and withdrawn after 6 wk."1.36Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. ( Bartalena, L; Compri, E; Lai, A; Marino, F; Piantanida, E; Sassi, L; Sivelli, P; Tanda, ML, 2010)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, CG1
Zhang, T1
Yue, FG1
Yi, ML1
Gao, D1
Xia, L1
Chen, GH1
Li, ZH1
Jiang, S1
Shen, J1
Carney, RM1
Freedland, KE1
Steinmeyer, B1
Rubin, EH1
Mann, DL1
Rich, MW1
Richardson, GS1
Zammit, G1
Wang-Weigand, S1
Zhang, J1
Lai, A1
Sassi, L1
Compri, E1
Marino, F1
Sivelli, P1
Piantanida, E1
Tanda, ML1
Bartalena, L1
Mazur, A1
Benvenga, S1
Ruggeri, RM1
Russo, A1
Lapa, D1
Campenni, A1
Trimarchi, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 3, Open-label, Fixed-dose Study to Determine the Safety of Long-term Administration of TAK-375 in Subjects With Chronic Insomnia[NCT00671086]Phase 31,213 participants (Actual)Interventional2003-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

4 trials available for thyroxine and Sleep Initiation and Maintenance Disorders

ArticleYear
Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia.
    Cell biochemistry and biophysics, 2013, Volume: 67, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Anti-Anxiety Agents; Chronic Disease; Estazolam; Female; Humans;

2013
Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease.
    Psychosomatic medicine, 2016, Volume: 78, Issue:1

    Topics: Antidepressive Agents; Biomarkers; C-Reactive Protein; Causality; Cognitive Behavioral Therapy; Comb

2016
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4

    Topics: Adolescent; Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Indenes;

2009
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Administration, Oral; Adult; Asthenia; Biomarkers; Body Weight; Bone Density; Carnitine; Double-Blin

2001

Other Studies

3 other studies available for thyroxine and Sleep Initiation and Maintenance Disorders

ArticleYear
Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Adrenocorticotropic Hormone; Adult; Case-Control Studies; Corticotropin-Releasing Hormone; Female; G

2013
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:3

    Topics: Adult; Aged; Chi-Square Distribution; Female; Glucocorticoids; Graves Disease; Graves Ophthalmopathy

2010
Do cortisol and thyroxin correlate with nervousness and depression among male army veterans?
    Biological psychology, 1994, Volume: 37, Issue:3

    Topics: Adult; Anxiety; Arousal; Depression; Fatigue; Humans; Hydrocortisone; Male; Middle Aged; Sleep Initi

1994